
Financials
Revenue history (in m)
Filing timeliness
No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 425 days for 2020). 2 of 5 audited by a statutory auditor.
- 2023not filed
- 202221/08/2023
- 202114/12/2022
- 202014/12/2022
- 201907/04/2021
- 201813/02/2020
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.
Results vs industry
Industry
Offer
Website technology
- Website
- WordPress
Trademarks
The company holds 4 active trademarks registered with the Polish Patent Office. 17 marks have expired or were not registered. The first mark was filed in 2013.
| Mark | Protected until | |
|---|---|---|
| NASOPRONAL (word) | May 25, 2030 | |
| AZYPRONAL (word) | May 25, 2030 | |
| TRANSBUPREMAX (word) | Feb 15, 2027 | |
| BEHISTEP (word) | Dec 24, 2034 | |
| VITAMA NATURE | – |
Authorized Representatives
Manner of representation
Each member of the management board acting independently
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Elopharm sp. z o.o. | 13,506.21 USD | 50% |
Bank accounts
Was a VAT taxpayer from 2012-09-01 to 2026-08-04.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
8 closed proceedings recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Mar 31, 2026 | Discontinued enforcement proceedings | Closed | |
| Mar 31, 2026 | Discontinued enforcement proceedings | Closed | |
| May 31, 2025 | Discontinued enforcement proceedings | Closed | |
| Dec 23, 2024 | Discontinued enforcement proceedings | Closed | |
| Dec 12, 2024 | Discontinued enforcement proceedings | Closed |
MSiG notices
| Publication date | Event | |
|---|---|---|
| May 19, 2022 | Call to creditors |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 16, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jan 23, 2019 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| Nov 21, 2017 | Regional investment aid | –– | Minister Funduszy i Polityki Regionalnej |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aristo Pharma sp. z o.o. | $22,775,627.72 | aristo-pharma.pl | ||
| Orifarm Healthcare sp. z o.o. | $11,159,864.42 | orifarmhealth.pl | ||
| Fortis Pharmaceuticals sp. z o.o. | $6,911,557.57 | fortispharmaceuticals.pl | ||
| Ethifarm sp. z o.o. + limited partnership | $5,691,422.61 | ethifarm.pl | ||
| Adpharma sp. z o.o. | $5,595,917.60 | adamed.com | ||
| Neupharm sp. z o.o. | $4,870,126.36 | neupharm.com.pl | ||
| Cosma S.A. | $3,421,832.81 | cosma.pl | ||
| Elanda Pharma sp. z o.o. | $2,725,664.09 | elanda.pl | ||
| Solinea Pharmaceuticals sp. z o.o. | $1,051,452.37 | solinea.pl | ||
| Goodwill Pharma Polska sp. z o.o. | $664,724.30 | goodwillpharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-08-30 | Address change (Bonifraterska 17, 00-203, Warszawa → Powsińska 106, 02-903, Warszawa) | |
| 2022-11-30 | Share capital increase (30,467,100.00 PLN → 30,476,100.00 PLN) | |
| 2022-09-28 | Share capital reduction (32,770,000.00 PLN → 30,467,100.00 PLN) | |
| 2017-02-07 | Share capital increase (15,100,000.00 PLN → 32,770,000.00 PLN) | |
| 2016-11-29 | Share capital increase (100,000.00 PLN → 15,100,000.00 PLN) |
FAQ
Last updated: 2026-10-27